With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Alleviant Medical announced today that it brought in $90 million to fund the second pivotal trial of its atrial shunt ...

Medtronic (NYSE: MDT) says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension.

Haemonetics announced today that it has completed its previously announced sale of its whole blood assets to GVS S.p.A.

Virtuoso Surgical announced today that it took part in a federal program aiming to bring together surgical robotics and AI.

CMR Surgical announced today that it appointed Massimiliano Colella as its new CEO and as a member of the board of directors.